Racial disparities in tissue plasminogen activator treatment rate for stroke: A population-based study

Stroke

Volumn 42, Issue 8, 2011, Pages 2217-2221

  Hsia, Amie W ^a,b   Edwards, Dorothy F ^c   Morgenstern, Lewis B ^d   Wing, Jeffrey J ^d   Brown, Nina C ^b   Coles, Regina ^c   Loftin, Sarah ^b   Wein, Andrea ^b   Koslosky, Sara S ^b   Fatima, Sabiha ^e   Sánchez, Brisa N ^d   Fokar, Ali ^g   Gibbons, M Chris ^f   Shara, Nawar ^g   Jayam Trouth, Annapurni ^e   Kidwell, Chelsea S ^b,h  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e HOWARD UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g MEDSTAR RESEARCH INSTITUTE   (United States)

^h Georgetown Stroke Center   (United States)

Author keywords

acute stroke; African American; disparities; race; thrombolytic therapy; tPA

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; COLOMBIA; CONTROLLED STUDY; DISEASE SEVERITY; ETHNICITY; FEMALE; HEALTH INSURANCE; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; NEGRO; ONSET AGE; PATIENT TRANSPORT; PRIORITY JOURNAL; RACE DIFFERENCE; STROKE; URBAN POPULATION;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBRINOLYTIC AGENTS; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 79961208585     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.613828     Document Type: Article

References (18)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
2. Katzan IL, Hammer MD, Hixson ED, Furlan AJ, Abou-Chebl A, Nadzam DM. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol. 2004;61:346-350. (Pubitemid 38327350)
3. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG, Wang DZ. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals [Editorial Comment]. Stroke. 2001;32:1832-1840.
4. Ayala C, Croft JB, Greenlund KJ, Keenan NL, Donehoo RS, Malarcher AM, Mensah GA. Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998. Stroke. 2002;33:1197-1201. (Pubitemid 34517035)
5. McGruder HF, Greenlund KJ, Croft JB, Zheng ZJ. Differences in disability among black and white stroke survivors-United States, 2000-2001. MMWR Morb Mortal Wkly Rep. 2005;54:3-6.
6. Morgenstern LB, Wein TH, Smith MA, Moye LA, Pandey DK, Labarthe DR. Comparison of stroke hospitalization rates among Mexican-Americans and non-Hispanic whites. Neurology. 2000;54:2000-2002. (Pubitemid 30327127)
7. Kothari R, Jauch E, Broderick J, Brott T, Sauerbeck L, Khoury J, Liu T. Acute stroke: delays to presentation and emergency department evaluation. Ann Emerg Med. 1999;33:3-8. (Pubitemid 29028773)
8. Johnston SC, Fung LH, Gillum LA, Smith WS, Brass LM, Lichtman JH, Brown AN, Wang DZ. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity: editorial comment: it is time to implement stroke practice improvement programs and prevent the racial disparity in stroke care. Stroke. 2001;32:1061-1068.
9. Kleindorfer D, Schneider A, Kissela BM, Woo D, Khoury J, Alwell K, Miller R, Gebel J, Szaflarski J, Pancioli A. The effect of race and gender on patterns of rt-PA use within a population. J Stroke Cerebrovasc Dis. 2003;12:217-220. (Pubitemid 37532149)
10. Evans A, Duckworth S, Kalra L, Claiborne Johnston S, Gillum LA, Smith WS. Racism and tPA use in African-Americans. Stroke. 2001;32:2439.
11. Schulman KA, Berlin JA, Harless W, Kerner JF, Sistrunk S, Gersh BJ, Dube R, Taleghani CK, Burke JE, Williams S, Eisenberg JM, Escarce JJ, Ayers W. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med. 1999;340:618-626. (Pubitemid 29093722)
12. van Ryn M, Fu SS. Paved with good intentions: do public health and human service providers contribute to racial/ethnic disparities in health? Am J Public Health. 2003;93:248-255. (Pubitemid 36159390)
13. Bernadette B-A, Josh S, Thania P, Laura E, Harmon M, Clinton W, Joyce M-H, Margaret D, Myunghee CP. A stroke preparedness RCT in a multiethnic cohort: Design and methods. Contemp Clin Trials. 2010;31:235-241.
14. Schwamm LH, Reeves MJ, Pan W, Smith EE, Frankel MR, Olson D, Zhao X, Peterson E, Fonarow GC. Race/ethnicity, quality of care, and outcomes in ischemic stroke. Circulation. 2010;121:1492-1501.
15. Skinner J, Chandra A, Staiger D, Lee J, McClellan M. Mortality after acute myocardial infarction in hospitals that disproportionately treat black patients. Circulation. 2005;112:2634-2641. (Pubitemid 41532600)
16. Bradley EH, Herrin J, Wang Y, McNamara RL, Webster TR, Magid DJ, Blaney M, Peterson ED, Canto JG, Pollack, Charles V Jr, Krumholz HM. Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA. 2004;292: 1563-1572. (Pubitemid 39314962)
17. Karve SJ, Balkrishnan R, Mohammad YM, Levine DA. Racial/ethnic disparities in emergency department waiting time for stroke patients in the United States. J Stroke Cerebrovasc Dis. 2010 Jun 9 [Epub ahead of print].
18. Hsia A, Castle A, Wing J, Edwards D, Brown N, Higgins T, Wallace J, Koslosky S, Gibbons M, Sanchez B, Fokar A, Shara N, Morgenstern L, Kidwell C. Understanding reasons for delay in seeking acute stroke care in an underserved urban population. Stroke. 2011;42:1697-1701.